GAM Systematic’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.75M Buy
13,478
+2,833
+27% +$378K 0.25% 143
2017
Q2
$1.41M Buy
10,645
+4,662
+78% +$571K 0.2% 195
2017
Q1
$737K Buy
5,983
+366
+7% +$43.3K 0.14% 276
2016
Q4
$620K Hold
5,617
0.15% 282
2016
Q3
$663K Sell
5,617
-514
-8% -$60.6K 0.14% 303
2016
Q2
$686K Buy
6,131
+3,300
+117% +$355K 0.17% 249
2016
Q1
$285K Sell
2,831
-3,856
-58% -$370K 0.08% 421
2015
Q4
$710K Sell
6,687
-10,543
-61% -$1.09M 0.2% 205
2015
Q3
$1.61M Sell
17,230
-22,691
-57% -$2.35M 0.37% 44
2015
Q2
$4.16M Sell
39,921
-11,893
-23% -$1.24M 0.53% 46
2015
Q1
$5.61M Buy
51,814
+17,590
+51% +$1.81M 0.77% 9
2014
Q4
$3.17M Buy
+34,224
New +$3.02M 0.64% 18

Other funds holding LH

GAM Systematic's LH Position: Q3 2017 in Review

GAM Systematic increased its Labcorp (LH) stake by 27% in Q3 2017, buying an estimated $378K and bringing the position to 13,478 shares worth $1.75M. The position accounts for 0.25% of the portfolio, ranked #143.

GAM Systematic first reported a position in LH in Q4 2014 and has held it in 12 quarters since. The position peaked at $5.61M in Q1 2015. 701 funds tracked by Wall St. Rank hold LH as of Q3 2017.

  • GAM Systematic held 13,478 shares of Labcorp worth $1.75M as of Q3 2017.
  • GAM Systematic bought 2,833 Labcorp shares in Q3 2017, an estimated $378K.
  • Labcorp made up 0.25% of GAM Systematic's portfolio in Q3 2017, its #143 holding.
  • GAM Systematic first reported a position in Labcorp in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Labcorp position peaked at $5.61M in Q1 2015.
  • 701 funds tracked by Wall St. Rank held Labcorp as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.